Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 400 of 1,261
  1. US 10766864

    Morphinan derivatives for the treatment of neuropathic pain

    Nektar Therapeutics · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  2. US 10765776

    Tissue-derived biomaterial composition and methods for ocular and other therapeutic applications

    SOUTH DAKOTA BOARD OF REGENTS (SDBOR) · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  3. US 10766858

    Substituted benzamides and methods of use thereof

    Xenon Pharmaceuticals Inc. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  4. US 10766890

    Hepatitis B core protein modulators

    ASSEMBLY BIOSCIENCES, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  5. US 10765762

    Humanized model of kidney and liver disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  6. US 10765745

    Multifunctional nanoparticle systems and methods for cancer diagnosis and combination therapy

    The Board of Regents of the University of Texas System · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  7. US 10767184

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  8. US 10765727

    Compositions and methods for producing dendritic cells

    PrimeVax Immuno-Oncology · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  9. US 10768167

    Plasma membrane citrate transporter for use in the diagnosis and treatment of cancer

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  10. US 10767177

    Sterol regulatory element binding protein (SREBP) chaperone (SCAP) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  11. US 10765687

    Methods and compounds to inhibit enveloped virus release

    Northwestern University · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  12. US 10765759

    Methods of treating an ocular disease or disorder

    The Regents of the University of California · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  13. US 10765683

    Stable formulations for parenteral injection of small molecule drugs

    XERIS PHARMACEUTICALS, INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  14. US 10765636

    Mesoporous silica nanoparticles with a lipid bilayer coating for cargo delivery

    The Regents of the University of California · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  15. US 10765600

    Adapter for use in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  16. US 10765646

    Methods of treating developmental encephalopathies

    OVID THERAPEUTICS INC. · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted
  17. US 2020276276

    PTH Prodrugs

    ASCENDIS PHARMA BONE DISEASES AS [DK] · Granted Sep 3, 2020 · Expires Aug 29, 2040

    granted
  18. US 10758488

    Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

    Jazz Pharmaceuticals, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  19. US 10758595

    Treatment of retinitis pigmentosa using engineered meganucleases

    Precision BioSciences, Inc. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  20. US 10758511

    Stable analogs of CYP450 lipid metabolites and inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  21. US 10760076

    Use of single-stranded antisense oligonucleotide in prevention or treatment of genetic diseases involving a trinucleotide repeat expansion

    ProQR Therapeutics II B.V. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  22. US 10759905

    Biodegradable amphiphilic polymer, polymeric vesicles prepared therefrom, and application of biodegradable amphiphilic polymer in preparation of medicines for targeted therapy of lung cancer

    BrightGene Bio-Medical Technology Co., Ltd. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  23. US 10759813

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted
  24. US 10759793

    2-(pyrazolopyridin-3-yl)pyrimidine derivatives as JAK inhibitors

    Almirall, S.A. · Granted Sep 1, 2020 · Expires Aug 27, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.